NDC 80489-757 Drs. Pharmacy Triple Antibiotic Plus
Bacitracin Zinc,Neomycin Sulfate,Polymyxin B Sulfate,Lidocaine Ointment Topical - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
Code Structure Chart
Product Details
What is NDC 80489-757?
What are the uses for Drs. Pharmacy Triple Antibiotic Plus?
What are Drs. Pharmacy Triple Antibiotic Plus Active Ingredients?
- BACITRACIN ZINC 400 [USP'U]/1000mg - A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)
- NEOMYCIN SULFATE 3.5 mg/1000mg - Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.
- POLYMYXIN B SULFATE 5000 [USP'U]/1000mg - A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic.
- PRAMOXINE HYDROCHLORIDE 10 mg/1000mg
Which are Drs. Pharmacy Triple Antibiotic Plus UNII Codes?
The UNII codes for the active ingredients in this product are:
- PRAMOXINE HYDROCHLORIDE (UNII: 88AYB867L5)
- PRAMOXINE (UNII: 068X84E056) (Active Moiety)
- BACITRACIN ZINC (UNII: 89Y4M234ES)
- BACITRACIN (UNII: 58H6RWO52I) (Active Moiety)
- NEOMYCIN SULFATE (UNII: 057Y626693)
- NEOMYCIN (UNII: I16QD7X297) (Active Moiety)
- POLYMYXIN B SULFATE (UNII: 19371312D4)
- POLYMYXIN B (UNII: J2VZ07J96K) (Active Moiety)
Which are Drs. Pharmacy Triple Antibiotic Plus Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PETROLATUM (UNII: 4T6H12BN9U)
What is the NDC to RxNorm Crosswalk for Drs. Pharmacy Triple Antibiotic Plus?
- RxCUI: 1999890 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5,000 UNT / pramoxine HCl 10 MG per GM Topical Ointment
- RxCUI: 1999890 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
- RxCUI: 1999890 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5,000 UNT / pramoxine hydrochloride 10 MG per GM Topical Ointment
Which are the Pharmacologic Classes for Drs. Pharmacy Triple Antibiotic Plus?
* Please review the disclaimer below.
Patient Education
Neomycin, Polymyxin, and Bacitracin Topical
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
[Learn More]
Pramoxine
Pramoxine is used to temporarily relieve pain and itching from insect bites; poison ivy, poison oak, or poison sumac; minor cuts, scrapes, or burns; minor skin irritation or rashes; or dry, itchy skin. Pramoxine also may be used to treat soreness, burning, itching, and pain from hemorrhoids (''piles'') and other minor rectal irritations or itching. Pramoxine is in a class of medications called topical anesthetics. It works by stopping nerves from sending pain signals.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".